Pacemaker
58
14
14
31
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.7%
1 terminated out of 58 trials
96.9%
+10.3% vs benchmark
5%
3 trials in Phase 3/4
10%
3 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 31 completed trials
Clinical Trials (58)
Virtual E-health System for Pacemakers
3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and Clinical Outcomes in Patients With Cardiac Implantable Electronic Device
PACE Cognition Proof-of-Concept Study
RAFT - Pace &Ablate
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
Elevated Rate Pacing of Cardiac Amyloidosis
Comparison of Upper Extremity Function, Physical Activity Levels and Peripheral Muscle Strength, Fear of Movement, Balance, Activities of Daily Living and Quality of Life in Patients With Pacemakers According to Pacemaker Type
Trial Evaluating the Benefit of Left Bundle Branch Area Stimulation Compared With Conventional Pacing in Post-TAVI Atrioventricular Atrioventricular Block
Postcards to Improve Remote Monitoring Connectivity Among Veterans With a Disconnected CIED
Postcards to Improve Remote Monitoring Connectivity Among Veterans With a Disconnected Monitor
A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP (France LEADLESS)
Effect of Clinical Pharmacist Consultation on Pain Management
Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis
Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices: The RAPTOR-CIED Study (Main Phase)
OPTimising a Screening Program to Detect Pacemaker-associated Heart Failure Using Artificial Intelligence
Prospective Study of Lead-associated Tricuspid Regurgitation in Patients Undergoing New Transvalvular Lead Insertion
Leadless Pacemaker Registry: Outcomes and Follow-up From the University Hospital of St. Pölten
Cardiovascular Performance and Exercise Response in Patients With Persistent or Permanent Atrial Fibrillation and Heart Failure Pre and Post Cardioversion or Pace and Ablate
Ultrasound-guided Axillary Vein Access Versus Cephalic Venous Cutdown for Implantation of Cardiac Electronic Devices.
Correct Mobilization Time After Implantation of an Intracardiac Electronic Device Implantation